Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Revenue (2022 - 2026)

Cannabis Bioscience International Holdings filings provide 5 years of Revenue readings, the most recent being $11205.0 for Q1 2026.

  • On a quarterly basis, Revenue fell 24.95% to $11205.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $123627.0, a 64.05% decrease, with the full-year FY2025 number at $303022.0, up 21.77% from a year prior.
  • Revenue reached $11205.0 in Q1 2026 per CBIH's latest filing, down from $53266.0 in the prior quarter.
  • The five-year high for Revenue was $178887.0 in Q3 2024, with the low at $11205.0 in Q1 2026.
  • A 5-year average of $58627.1 and a median of $52259.0 in 2023 define the central range for Revenue.
  • Year-over-year, Revenue soared 145.65% in 2024 and then tumbled 86.47% in 2025.
  • Year by year, Revenue stood at $82581.0 in 2022, then fell by 22.81% to $63748.0 in 2023, then grew by 16.47% to $74248.0 in 2024, then fell by 28.26% to $53266.0 in 2025, then crashed by 78.96% to $11205.0 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Revenue are $11205.0 (Q1 2026), $53266.0 (Q4 2025), and $24200.0 (Q3 2025).